Furthermore, there may be significant variations in immune cell infiltration and metabolic activity across different regions of the tumor, which may hinder the comprehensive reflection of this complexity by FDG metabolic parameters.
← all excerpts
Prognostic and Predict Value of Peripheral Blood Circulating Tumor Cells Programmed Death-Ligand 1 Expression and F-18-Fluorodeoxyglucose Metabolic Parameters in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
1
—
—